Bernice Kuca

Bernice Kuca discloses dealings in CoLucid Pharmaceuticals, Inc. to SEC (Form 4). Over a trading history stretching from 4 March 2016 to 1 March 2017, the count stands at 5 filings.

No open-market purchase appears, only 2 sales worth €52k. Besides market trades, the filings include 1 share grant. So far in 2017, the count stands at no purchases and 1 sale.

The newest entry dates from 1 March 2017: a transaction of €120k, in CoLucid Pharmaceuticals, Inc. Most trades are made public on the day they happen. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.